Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 22 Carcinoma, Hepatocellular 15 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 9 Neoplasms 8 Colorectal Neoplasms 6 Breast Neoplasms 6 Urinary Bladder Neoplasms 5 Lung Neoplasms 5 Carcinoma, Renal Cell 5 Ovarian Neoplasms 4 Carcinoma, Transitional Cell 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Colonic Neoplasms 2 Venous Thrombosis 1 Urologic Neoplasms 1 Stomach Neoplasms 1 Squamous Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Rectal Neoplasms 1 Radiation Pneumonitis 1 Prostatic Neoplasms, Castration-Resistant 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Non-Small-Cell Lung 1

Interventions

Trastuzumab 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 pertuzumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Lapatinib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Invasive Breast Cancer × atezolizumab × Clear all

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡